Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Seminars in Arthritis and Rheumatism
|
June 20, 2025
Two clinical subgroups of immune checkpoint inhibitor-induced inflammatory arthritis determined by latent class analysis
Laura C Cappelli, Jamie Perin, Scott Zeger, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2024
Corticosteroid-resistant immune-related adverse events: a systematic review
Eveline Daetwyler, Till Wallrabenstein, David König, et al.
Human Pathology
|
July 8, 2019
Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma
Erika F Rodriguez, Evan Lipson, Karthik Suresh, et al.
BMC Rheumatology
|
August 9, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps
Laura C Cappelli, Suzanne M Grieb, Ami A Shah, et al.
The Journal of Dermatological Treatment
|
March 3, 2021
Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses
Thomas K Le, Subuhi Kaul, Laura C Cappelli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 15, 2017
Two Cases of Sinusitis Induced by Immune Checkpoint Inhibition
Eric Dein, William Sharfman, Jean Kim, et al.
Journal of Cancer Research and Clinical Oncology
|
September 14, 2022
Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team
Christopher Fan, Ahyoung Kim, Sean Li, et al.
The Journal of Rheumatology
|
February 15, 2024
Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry
Dimitrios A Pappas, Jacqueline O'Brien, Page C Moore, et al.
The Journal of Rheumatology
|
January 15, 2026
Hip osteoarthritis is not a risk factor for immune checkpoint inhibitor-induced inflammatory arthritis
Rebecca Fitzpatrick, Shadpour Demehri, Joseph Murray, et al.
The Journal of Rheumatology
|
April 15, 2026
Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
Rebecca Fitzpatrick, Shadpour Demehri, Joseph Murray, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Seminars in Arthritis and Rheumatism
|
June 20, 2025
Two clinical subgroups of immune checkpoint inhibitor-induced inflammatory arthritis determined by latent class analysis
Laura C Cappelli, Jamie Perin, Scott Zeger, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2024
Corticosteroid-resistant immune-related adverse events: a systematic review
Eveline Daetwyler, Till Wallrabenstein, David König, et al.
Human Pathology
|
July 8, 2019
Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma
Erika F Rodriguez, Evan Lipson, Karthik Suresh, et al.
BMC Rheumatology
|
August 9, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps
Laura C Cappelli, Suzanne M Grieb, Ami A Shah, et al.
The Journal of Dermatological Treatment
|
March 3, 2021
Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses
Thomas K Le, Subuhi Kaul, Laura C Cappelli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 15, 2017
Two Cases of Sinusitis Induced by Immune Checkpoint Inhibition
Eric Dein, William Sharfman, Jean Kim, et al.
Journal of Cancer Research and Clinical Oncology
|
September 14, 2022
Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team
Christopher Fan, Ahyoung Kim, Sean Li, et al.
The Journal of Rheumatology
|
February 15, 2024
Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry
Dimitrios A Pappas, Jacqueline O'Brien, Page C Moore, et al.
The Journal of Rheumatology
|
January 15, 2026
Hip osteoarthritis is not a risk factor for immune checkpoint inhibitor-induced inflammatory arthritis
Rebecca Fitzpatrick, Shadpour Demehri, Joseph Murray, et al.
The Journal of Rheumatology
|
April 15, 2026
Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
Rebecca Fitzpatrick, Shadpour Demehri, Joseph Murray, et al.
Page
of 6